Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Intellia Therapeutics Announces That FDA Has Placed A Clinical Hold On The Investigational New Drug Applications For The MAGNITUDE And MAGNITUDE-2 Phase 3 Clinical Trials For Nexiguran Ziclumeran

Author: Benzinga Newsdesk | October 29, 2025 03:27pm

-SEC Filing

Posted In: NTLA